benefits of tirzepatide over semaglutide vs GLP-1 Medications for Weight Loss:

This helps promote insulin release, delays gastric emptying, and enhances feelings of satiety

Importantly, 57% of participants achieved at least 20% weight loss a threshold previously considered impossible with pharmacotherapy alone

A 2021 study published in the New England Journal of Medicine found that semaglutide 0.4 mg daily led to resolution of non-alcoholic steatohepatitis (NASH) in 59% of participants compared to 17% in the placebo group

Note that upper arm injections typically require assistance from another person

Can people with diabetes drink diet soda

Do not freeze the medication, as this can break down the proteins and make it ineffective